Celator Pharmaceuticals Inc., clinical-stage biopharmaceuticals company focused on cancer treatment, has raised US$32.5 million in the final closing of a private placement of common stock and warrants to purchase common stock. The deal was led by U.S. venture capital firm Valence Life Sciences. Celator, which has offices in Vancouver and Princeton, New Jersey, has been venture-backed since 2002. Its other investors include BDC Venture Capital, Domain Associates, GrowthWorks, Hearthstone Investment, Quaker BioVentures, TL Ventures and Ventures West Capital.
You are browsing the archive for Domain Associates - peHUB.
Fabrice Egros has been appointed COO, pharmaceutical director and board member of NovaMedica. The business was established as part of the $760 million collaboration between the Russian high technology investment fund RUSNANO and the American health care venture fund Domain Associates.
RightCare Solutions has secured $1.75 million in Series A funding led by Compass Partners and Domain Associates. RightCare, of Ft. Washington, Pa., specializes in hospital discharge planning and readmission management.
Apnex Medical has secured financing totaling $10 million from New Enterprise Associates. The funds will be used to support the ongoing Apnex Clinical Study. Apnex develops medical devices aimed at helping people with sleep apnea. Other investors in the company include Domain Associates, Polaris Venture Partners and investor and Apnex chairman Michael Berman.
Tobira Therapeutics, a developer of innovative antiretroviral therapies for HIV, has appointed three executives in the finance, clinical and pharmaceutical sciences functions. Caroline Loewy joins the company as executive vice president and chief financial officer, Jeff Enejosa, M.D., as senior director, clinical research, and Mark Menning as director, pharmaceutical sciences. Tobira has financial backing from [...]
CoDa Therapeutics has raised an additional $20 million from RusnanoMedInvest in a second close of its Series B financing round. This brings the total Series B Round to nearly $40 million following the first close late last year. All current investors, including Domain Associates, GBS Ventures and BioPacificVentures participated. San Diego-based CoDa is a biopharmaceutical [...]
Astute Medical, the San Diego-based biomarker-based medical diagnostics firm, took in more than $40 million in a big Series C round, the company revealed. The financing was led by MPM Capital, and included new investor Kaiser Permanente Ventures. Prior backers De Novo Ventures, Delphi Ventures, Domain Associates and Johnson & Johnson Development Corporation also joined [...]
Benvenue Medical, a developer of minimally invasive solutions for spine repair, has appointed two new members to its board of directors. Thomas M. Prescott, president and CEO of Align Technology and Thomas C. Wilder, president and CEO of Sequent Medical are both experienced in bringing medical technologies to the global marketplace. Investors in Benvenue Medical [...]
Russian state technology firm Rusnano is teaming up with a US venture fund, writes Reuters. Rusnano and life sciences technologies investor Domain Associates are planning to co-invest in about 20 US-based healthcare technology companies. Rusnano will invest up to $330 million and Domain’s venture capital funds and other investors will invest a like amount, according [...]
Carticept Medical Inc., a developer of treatments for cartilage injuries and osteoarthritis, has raised $10 million in financing led by existing investors Domain Associates, New Enterprise Associates and SonoSite Inc. The money is aimed at commercial launch of the company’s computer-controlled drug delivery system. In total, Carticept has raised $53 million from investors.